AFDN and metabolic dysfunction-associated steatohepatitis: To gain more insight into the role of AF6 in in vivo pathogenicity, we established a NASH model by maintaining mice on a HFHC diet for 16 weeks and AF6 levels (at both the mRNA and protein levels) were elevated in the mouse HFHC model (Fig. 1b, e).